Page 60 - SPEMD_59-2

118 rev port estomatol med dent cir maxilofac. 2018;59(2):115-118

In conclusion, according to our literature review, the head 11. Anadolu R, Akay BN, Bodamyali P, et al. Giant
and neck giant KA is usually a rapid growth benign tumor with keratoacanthoma -type low -grade squamous cell carcinoma
a low propensity for recurrence or metastasis that presents a of the upper lip: response to intralesional interferon
alpha -2B. J Dermatolog Treat. 2011;22:239-40.
predilection for male patients, affects mostly the nose and is 12. Lucente FE. Giant keratoacanthoma of the nose. Otolaryngol
commonly treated by surgery alone. The case report here pre- Head Neck Surg. 1985;93:112-6.
sented revealed that tumor excision is an effective treatment 13. Phiske MM, Avhad G, Jerajani, HR. Keratoacanthoma
and aesthetic principles need to be taken into account to have centrifugum marginatum at an unusual site. Indian journal
an optimal treatment and patient satisfaction. of dermatology. 2013;58:74.
14. Browne F, O’Connell M, Merchant W, et al. Spontaneous
resolution of a giant keratoacanthoma penetrating through
Ethical disclosures the nose. Clin Exp Dermatol. 2011;36:369-71.
15. Edelman BA, Jacobs JB, Rotterdam H, et al. Giant
keratoacanthoma: an atypical presentation. Otolaryngol
Protection of human and animal subjects. The authors de- Head Neck Surg. 1990;103:472-5.
clare that no experiments were performed on humans or an- 16. Saito M, Sasaki Y, Yamazaki N, et al. Self -involution of giant
imals for this study. keratoacanthoma on the tip of the nose. Plast Reconstr Surg.
2003;111:1561-2.
Confidentiality of data. The authors declare that they have 17. Grob JJ, Suzini F, Richard MA, et al. Large keratoacanthomas
followed the protocols of their work center on the publication treated with intralesional interferon alfa -2a. J Am Acad
of patient data. Dermatol. 1993;29:237-41.
18. Spieth K, Gille J, Kaufmann R. Intralesional methotrexate as
Right to privacy and informed consent. The authors have ob- effective treatment in solitary giant keratoacanthoma of the
tained the written informed consent of the patients or sub- lower lip. Dermatology. 2000;200:317-9.
jects mentioned in the article. The corresponding author is in 19. Rapaport J. Giant keratoacanthoma of the nose. Arch
possession of this document. Dermatol. 1975;111:73-5.
20. Pagani WA, Lorenzi G, Lorusso D. Surgical treatment for
aggressive giant keratoacanthoma of the face. J Dermatol
Surg Oncol. 1986;12:282-4.
Conflicts of interest 21. Salam MA, Bickerton RC. Giant keratoacanthoma of the nasal
vestibule. Br J Clin Pract. 1995;49:52.
The authors have no conflicts of interest to declare. 22. Guimarães EP, de Carli ML, Sperandio FF, Pereira AA,
Hanemann JA. Giant keratoacanthoma of the lower lip: case
report and review of the published literature. General Dent.
references 2016;64:22 -5.
23. Santoso -Pham JC, Shelley ED, Shelley WB. Aggressive giant
1. Bogner PN, Cheney RT, Zeitouni NC. Giant keratoacanthoma: keratoacanthoma of the face treated with intramuscular
case report and review of the English literature. The methotrexate and triamcinolone acetonide. Cutis.
American Journal of Dermatopathology. 2014;36:252 -7. 1997;59:329-32.
2. Alyahya GA, Heegaard S, Prause JU. Malignant changes in a 24. Kyrmizakis DE, Hajiioannou JK, Helidonis E. Giant
giant orbital keratoacanthoma developing over 25 years. Acta keratoacanthoma of the lower lip. Otolaryngol Head Neck
Ophthalmol Scand. 2000;78:223-5. Surg. 2003;128:904-5.
3. Moriyama M, Watanabe T, Sakamoto N, et al. A case of giant 25. Hofer SO, Jackson IT. Self -involution of giant
keratoacanthoma of the auricle. Auris Nasus Larynx. keratoacanthoma on the tip of the nose. Plastic and
2000;27:185-8. reconstructive surgery. 2004;113:765 -6.
4. Yang Y, Xu Y, Wang L, Liao W, Gao T, Ma C. Two cases of giant 26. Tsikeloudi M, Lallas A, Sidiropoulos T, Chasioti V, Lefaki I,
keratoacanthoma centrifugum marginatum accompanied by Apalla Z. Imiquimod as neoadjuvant treatment for giant
α‐human papillomavirus infection. International journal of keratoacanthoma arising on a background of lupus vulgaris.
dermatology. 2015;54:951 -4. Clinical and experimental dermatology. 2014;39:60 -2.
5. de Visscher JG, van der Wal JE, Starink TM, et al. Giant 27. Bart RS, Popkin GL, Kopf AW, et al. Giant keratoacanthoma: a
keratoacanthoma of the lower lip. Report of a case of problem in diagnosis and management. J Dermatol Surg.
spontaneous regression. Oral Surg Oral Med Oral Pathol Oral 1975;1:49-55.
Radiol Endod. 1996;81:193-6. 28. Goldschmidt H, Sherwin WK. Radiation therapy of giant
6. de Visscher JG, van der Wal KG, Blanken R, Willemse F. aggressive keratoacanthomas. Arch Dermatol. 1993;129:1162-5.
Treatment of giant keratoacanthoma of the skin of the lower 29. Kopf AW, Bart RS. Tumor conference no. 17: giant
lip with intralesional methotrexate: a case report. J Oral keratoacanthoma. J Dermatol Surg Oncol. 1978;4:444-5.
Maxillofac Surg. 2002;60:93-5. 30. Liebman EP, Hauslein P. Giant keratoacanthoma of the ear.
7. Shah M, Green L, Kwok C. Self‐resolving invasive squamous Trans Pa Acad Ophthalmol Otolaryngol. 1977;30:197-202.
cell carcinoma or giant keratoacanthoma?. Clinical and 31. Karaa A, Khachemoune A. Keratoacanthoma: a tumor in
experimental dermatology. 2012;37:701 -2. search of a classification. Int J Dermatol. 2007;46:671 -8.
8. Leonard AL, Hanke CW. Treatment of giant keratoacanthoma 32. Savage JA, Maize JC Sr. Keratoacanthoma clinical behavior: a
with intralesional 5 -fluorouracil. J Drugs Dermatol. systematic review. Am J Dermatopathol. 2014;36:422 -9.
2006;5:454-6.
9. Kallos A. Giant keratoacanthoma. AMA Arch Derm. 1958;78:207-9.
10. Saftic M, Batinac T, Zamolo G, et al. HPV 6 -positive giant
keratoacanthoma in an immunocompetent patient. Tumori.
2006;92:79-82.